Changing Smoking Behavior and Epigenetics: A Longitudinal Study of 4,432 Individuals From the General Population

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Changing Smoking Behavior and Epigenetics : A Longitudinal Study of 4,432 Individuals From the General Population. / Skov-Jeppesen, Sune Moeller; Kobylecki, Camilla Jannie; Jacobsen, Katja Kemp; Bojesen, Stig Egil.

I: Chest, Bind 163, Nr. 6, 2023, s. 1565-1575.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Skov-Jeppesen, SM, Kobylecki, CJ, Jacobsen, KK & Bojesen, SE 2023, 'Changing Smoking Behavior and Epigenetics: A Longitudinal Study of 4,432 Individuals From the General Population', Chest, bind 163, nr. 6, s. 1565-1575. https://doi.org/10.1016/j.chest.2022.12.036

APA

Skov-Jeppesen, S. M., Kobylecki, C. J., Jacobsen, K. K., & Bojesen, S. E. (2023). Changing Smoking Behavior and Epigenetics: A Longitudinal Study of 4,432 Individuals From the General Population. Chest, 163(6), 1565-1575. https://doi.org/10.1016/j.chest.2022.12.036

Vancouver

Skov-Jeppesen SM, Kobylecki CJ, Jacobsen KK, Bojesen SE. Changing Smoking Behavior and Epigenetics: A Longitudinal Study of 4,432 Individuals From the General Population. Chest. 2023;163(6):1565-1575. https://doi.org/10.1016/j.chest.2022.12.036

Author

Skov-Jeppesen, Sune Moeller ; Kobylecki, Camilla Jannie ; Jacobsen, Katja Kemp ; Bojesen, Stig Egil. / Changing Smoking Behavior and Epigenetics : A Longitudinal Study of 4,432 Individuals From the General Population. I: Chest. 2023 ; Bind 163, Nr. 6. s. 1565-1575.

Bibtex

@article{a5a7866ccf904adebbcc57795ae35e39,
title = "Changing Smoking Behavior and Epigenetics: A Longitudinal Study of 4,432 Individuals From the General Population",
abstract = "Background: Hypomethylation of the aryl hydrocarbon receptor repressor (AHRR) gene indicates long-term smoking exposure and might therefore be a monitor for smoking-induced disease risk. However, studies of individual longitudinal changes in AHRR methylation are sparse. Research Question: How does the recovery of AHRR methylation depend on change in smoking behaviors and demographic variables? Study Design and Methods: This study included 4,432 individuals from the Copenhagen City Heart Study, with baseline and follow-up blood samples and smoking information collected approximately 10 years apart. AHRR methylation at the cg05575921 site was measured in bisulfite-treated leukocyte DNA. Four smoking groups were defined: participants who never smoked (Never-Never), participants who formerly smoked (Former-Former), participants who quit during the study period (Current-Former), and individuals who smoked at both baseline and follow-up (Current-Current). Methylation recovery was defined as the increase in AHRR methylation between baseline and follow-up examination. Results: Methylation recovery was highest among participants who quit, with a median methylation recovery of 5.58% (interquartile range, 1.79; 9.15) vs 1.64% (interquartile range, –1.88; 4.96) in the Current-Current group (P < .0001). In individuals who quit smoking, older age was associated with lower methylation recovery (P < .0001). In participants who quit aged > 65 years, methylation recovery was 5.9% at 5.6 years after quitting; methylation recovery was 8.5% after 2.8 years for participants who quit aged < 55 years. Interpretation: AHRR methylation recovered after individuals quit smoking, and recovery was more pronounced and occurred faster in younger compared with older interim quitters.",
keywords = "aryl hydrocarbon receptor repressor, DNA methylation, longitudinal study, lung cancer, smoking",
author = "Skov-Jeppesen, {Sune Moeller} and Kobylecki, {Camilla Jannie} and Jacobsen, {Katja Kemp} and Bojesen, {Stig Egil}",
note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",
year = "2023",
doi = "10.1016/j.chest.2022.12.036",
language = "English",
volume = "163",
pages = "1565--1575",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

RIS

TY - JOUR

T1 - Changing Smoking Behavior and Epigenetics

T2 - A Longitudinal Study of 4,432 Individuals From the General Population

AU - Skov-Jeppesen, Sune Moeller

AU - Kobylecki, Camilla Jannie

AU - Jacobsen, Katja Kemp

AU - Bojesen, Stig Egil

N1 - Publisher Copyright: © 2023 The Author(s)

PY - 2023

Y1 - 2023

N2 - Background: Hypomethylation of the aryl hydrocarbon receptor repressor (AHRR) gene indicates long-term smoking exposure and might therefore be a monitor for smoking-induced disease risk. However, studies of individual longitudinal changes in AHRR methylation are sparse. Research Question: How does the recovery of AHRR methylation depend on change in smoking behaviors and demographic variables? Study Design and Methods: This study included 4,432 individuals from the Copenhagen City Heart Study, with baseline and follow-up blood samples and smoking information collected approximately 10 years apart. AHRR methylation at the cg05575921 site was measured in bisulfite-treated leukocyte DNA. Four smoking groups were defined: participants who never smoked (Never-Never), participants who formerly smoked (Former-Former), participants who quit during the study period (Current-Former), and individuals who smoked at both baseline and follow-up (Current-Current). Methylation recovery was defined as the increase in AHRR methylation between baseline and follow-up examination. Results: Methylation recovery was highest among participants who quit, with a median methylation recovery of 5.58% (interquartile range, 1.79; 9.15) vs 1.64% (interquartile range, –1.88; 4.96) in the Current-Current group (P < .0001). In individuals who quit smoking, older age was associated with lower methylation recovery (P < .0001). In participants who quit aged > 65 years, methylation recovery was 5.9% at 5.6 years after quitting; methylation recovery was 8.5% after 2.8 years for participants who quit aged < 55 years. Interpretation: AHRR methylation recovered after individuals quit smoking, and recovery was more pronounced and occurred faster in younger compared with older interim quitters.

AB - Background: Hypomethylation of the aryl hydrocarbon receptor repressor (AHRR) gene indicates long-term smoking exposure and might therefore be a monitor for smoking-induced disease risk. However, studies of individual longitudinal changes in AHRR methylation are sparse. Research Question: How does the recovery of AHRR methylation depend on change in smoking behaviors and demographic variables? Study Design and Methods: This study included 4,432 individuals from the Copenhagen City Heart Study, with baseline and follow-up blood samples and smoking information collected approximately 10 years apart. AHRR methylation at the cg05575921 site was measured in bisulfite-treated leukocyte DNA. Four smoking groups were defined: participants who never smoked (Never-Never), participants who formerly smoked (Former-Former), participants who quit during the study period (Current-Former), and individuals who smoked at both baseline and follow-up (Current-Current). Methylation recovery was defined as the increase in AHRR methylation between baseline and follow-up examination. Results: Methylation recovery was highest among participants who quit, with a median methylation recovery of 5.58% (interquartile range, 1.79; 9.15) vs 1.64% (interquartile range, –1.88; 4.96) in the Current-Current group (P < .0001). In individuals who quit smoking, older age was associated with lower methylation recovery (P < .0001). In participants who quit aged > 65 years, methylation recovery was 5.9% at 5.6 years after quitting; methylation recovery was 8.5% after 2.8 years for participants who quit aged < 55 years. Interpretation: AHRR methylation recovered after individuals quit smoking, and recovery was more pronounced and occurred faster in younger compared with older interim quitters.

KW - aryl hydrocarbon receptor repressor

KW - DNA methylation

KW - longitudinal study

KW - lung cancer

KW - smoking

U2 - 10.1016/j.chest.2022.12.036

DO - 10.1016/j.chest.2022.12.036

M3 - Journal article

C2 - 36621758

AN - SCOPUS:85159892058

VL - 163

SP - 1565

EP - 1575

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -

ID: 362895307